VeriMomIst dihydrogenated palmoylethyl hydroxyethylmonium methosulfate in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment was identified for this specific quaternary ammonium salt, and no peer‑reviewed reproductive or developmental toxicity studies were found in PubMed for this exact ingredient. As a large, ionic quaternary ammonium conditioning agent it is not expected to be systemically absorbed to a significant extent from normal topical cosmetic use (sources searched: ECHA C&L, CosIng, PubChem, PubMed, CIR).
Pregnancy-safe products containing dihydrogenated palmoylethyl hydroxyethylmonium methosulfate
Related ingredients
Frequently asked questions
- Ist dihydrogenated palmoylethyl hydroxyethylmonium methosulfate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment was identified for this specific quaternary ammonium salt, and no peer‑reviewed reproductive or developmental toxicity studies were found in PubMed for this exact ingredient. As a large, ionic quaternary ammonium conditioning agent it is not expected to be systemically absorbed to a significant extent from normal topical cosmetic use (sources searched: ECHA C&L, CosIng, PubChem, PubMed, CIR).
- Ist dihydrogenated palmoylethyl hydroxyethylmonium methosulfate während des Stillens sicher?
- Same rationale as pregnancy: no harmonised hazard classification or specific reproductive/lactation studies located; expected minimal systemic exposure from topical cosmetic formulations so breastmilk exposure is unlikely under normal use (sources searched: ECHA C&L, CIR, PubMed, CosIng).
- Ist dihydrogenated palmoylethyl hydroxyethylmonium methosulfate sicher für Babyhaut?
- No infant‑specific reproductive or developmental data located. Adult topical dermal absorption is expected to be negligible for this high‑molecular‑weight/ionic quaternary ammonium compound (adult e=0), but because infant skin has higher permeability, exposure score increased by +1 for 0–3‑year skin (result e=1). No evidence was found to justify increasing hazard (h) or mechanism (m).
- Wie bewertet VeriMom dihydrogenated palmoylethyl hydroxyethylmonium methosulfate?
- VeriMom bewertet dihydrogenated palmoylethyl hydroxyethylmonium methosulfate mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu dihydrogenated palmoylethyl hydroxyethylmonium methosulfate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu dihydrogenated palmoylethyl hydroxyethylmonium methosulfate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.